Kyong Kim
Foot & Ankle Surgery · Fort Lee, NJNPI 1265888473
Payments from drug & device makers
Across 60 payments — averaging $74.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$1K
- Osteomed LLC$911
- Organogenesis Inc.$508
- Linvatec Corporation$425
- Kerecis Limited$313
- Smith+Nephew$238
- plus $646 from 11 others
What the payments were for
- Travel & lodging$2,46655%
- Food & beverage$2,00545%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 3 | $1,432 |
| Osteomed LLC | 6 | $911 |
| Organogenesis Inc. | 14 | $508 |
| Linvatec Corporation | 1 | $425 |
| Kerecis Limited | 5 | $313 |
| Smith+Nephew | 13 | $238 |
| Stryker | 1 | $172 |
| KCI USA, Inc. | 2 | $112 |
| Bsn Medical Inc | 2 | $81 |
| Integra Lifesciences Corporation | 4 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Urgo Medical North America, LLC | 1 | $33 |
| Kuros Biosciences USA, Inc | 1 | $29 |
| Zimmer Biomet | 1 | $27 |
| Tactile Systems Technology Inc | 1 | $26 |
| Medtronic | 1 | $21 |
| Advanced Oxygen Therapy Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXT-Other$677
- BioBrace 23mm$425
- Kerecis Omega3 Marigen$362
- PuraPly$245
- CITREFIX$172
- Kerecis Omega3 SurgiClose$121
- Kerecis Omega3 GraftGuide$121
How this compares
$4,472 in reported general payments places this provider in the 70th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 309 | $24,320 |
| Clotrimazole | 162 | $9,124 |
| Diclofenac Sodium ErDiclofenac Sodium | 107 | $8,245 |
| Fluconazole | 59 | $8,034 |
| Doxepin Hcl | 64 | $6,515 |
| Diclofenac Epolamine | 13 | $5,998 |
| Etodolac | 19 | $2,277 |
| Ketoconazole | 49 | $1,279 |
| Naproxen Sodium | 16 | $1,258 |
| Ammonium Lactate | 24 | $394 |
| Econazole Nitrate | 14 | $310 |
| Ibuprofen | 18 | $101 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Fort Lee
- Steven BernsteinFort Lee$47K
- Wayne BerberianNewark$2M
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$847K
- Shane HollawellManasquan$753K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Sheldon LinNewark$253K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.